Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-001492
Filing Date
2017-02-16
Accepted
2017-02-16 15:47:07
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4020917slager_oramed.html 4  
1 OWNERSHIP DOCUMENT f4020917slager_oramed.xml 4 3789
  Complete submission text file 0001213900-17-001492.txt   5423
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Reporting) CIK: 0001477733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 17617793